Evaluation of the Clinical Efficacy of the Treatment of Overweight and Obesity in Type 2 Diabetes Mellitus by the Telemedicine Management System Based on the Internet of Things Technology

Table 2

Comparison of each index in two groups before and after the treatment ().

Groups	n	Weight (kg)	BMI (kg/m^2)	HbA1c (%)	FPG (mmoL/L)	2hPG (mmoL/L)	HOMA-IR
Control group	25
Before the treatment		74.72 ± 8.54	27.78 ± 1.72	8.55 ± 0.71	10.07 ± 2.25	15.22 ± 3.89	3.76 ± 1.46
After the treatment		71.84 ± 6.78^a	26.79 ± 1.74^a	7.70 ± 0.39^a	8.12 ± 0.73^a	12.99 ± 2.46^a	3.12 ± 0.52^a
Joint group	25
Before the treatment		74.96 ± 7.43	28.04 ± 2.27	8.40 ± 0.61	10.79 ± 2.99	15.04 ± 3.64	3.67 ± 1.45
After the treatment		68.12 ± 5.46^ab	25.51 ± 1.82^ab	6.97 ± 0.51^ab	7.54 ± 0.78^ab	10.84 ± 1.58^ab	2.63 ± 0.67^ab
Groups	n	HOMA-β	SBP (mmHg)	DBP (mmHg)	TC (mmoL/L)	TG (mmoL/L)	LDL-cholesterol (C) (mmoL/L)
Control group	25
Before the treatment		14.55 ± 8.7	140.2 ± 16.61	82.76 ± 7.59	5.92 ± 1.44	2.82 ± 0.96	3.34 ± 0.87
After the treatment		17.96 ± 3.57^a	138.20 ± 13.84	80.76 ± 5.58	5.16 ± 1.23^a	2.24 ± 0.63^a	3.19 ± 0.86
Joint group	25
Before the treatment		11.99 ± 7.6	136.44 ± 13.70	79.84 ± 7.43	5.50 ± 1.6	3.08 ± 1.27	3.61 ± 0.61
After the treatment		17.30 ± 4.33^a	129.44 ± 13.22^ab	75.00 ± 5.41^ab	4.49 ± 1.12^a	2.34 ± 0.78^a	3.66 ± 0.79